4.4 Article

Pityriasis rosea following influenza (H1N1) vaccination

Journal

JOURNAL OF THE CHINESE MEDICAL ASSOCIATION
Volume 74, Issue 6, Pages 280-282

Publisher

ELSEVIER TAIWAN
DOI: 10.1016/j.jcma.2011.04.010

Keywords

Adverse reaction; H1N1 vaccination; Pandemic; Pityriasis rosea

Ask authors/readers for more resources

Pityriasis rosea is a distinct papulosquamous skin eruption that has been attributed to viral reactivation, certain drug exposures or rarely, vaccination. Herein, we reported a clinicopathlogically typical case of pityriasis rosea that developed after the H1N1 vaccination. With a global H1N1 vaccination program against the pandemic H1N1 influenza, patients should be apprised of the possibility of such rare but benign skin reaction to avoid unnecessary fear. Furthermore, a brief review of the current reported skin adverse events related to the novel H1N1 vaccination in Taiwan is presented here. Copyright (C) 2011 Elsevier Taiwan LLC and the Chinese Medical Association. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available